Non-affinity factors modulating vascular targeting of nano- and microcarriers

Advanced Drug Delivery Reviews

Volumn 99, Issue , 2016, Pages 97-112

  Myerson, Jacob W ^a   Anselmo, Aaron C ^b   Liu, Yaling ^c   Mitragotri, Samir ^a   Eckmann, David M ^a   Muzykantov, Vladimir R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LEHIGH UNIVERSITY   (United States)

Author keywords

Hemodynamics; Leukocytes; Nanomedicine; Pharmacokinetics; Platelets; Red blood cells; Targeted delivery; Vascular biology

Indexed keywords

EPITOPES; HEMODYNAMICS; LIGANDS; MEDICAL NANOTECHNOLOGY; PHARMACOKINETICS; PLATELETS;

EFFECT OF FACTORS; FUNDAMENTAL TOOLS; INTRACELLULAR TRAFFICKING; LEUKOCYTES; MITIGATING FACTOR; RED BLOOD CELL; TARGETED DELIVERY; VASCULAR BIOLOGY;

PATHOLOGY;

ARGINYLGLYCYLASPARTIC ACID; BIOLOGICAL MARKER; COPOLYMER; DRUG CARRIER; EPITOPE; LIPOSOME; MACROGOL; MICROCARRIER; MICROSPHERE; NANOCARRIER; NANOPARTICLE; POLYETHYLENE; POLYETHYLENEIMINE; POLYMER; POLYSTYRENE; UNCLASSIFIED DRUG;

BINDING AFFINITY; BLOOD VESSEL; DRUG DELIVERY SYSTEM; DRUG TARGETING; HEMODYNAMICS; HUMAN; INFLAMMATION; INTRACELLULAR TRANSPORT; LUNG DISEASE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; TARGET CELL; THROMBOSIS; ANIMAL; CHEMISTRY; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD VESSELS; DRUG CARRIERS; HEMODYNAMICS; HUMANS; NANOPARTICLES;

EID: 84960304693     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.10.011     Document Type: Review

References (205)

1. Hood E., Simone E., Wattamwar P., Dziubla T., Muzykantov V. Nanocarriers for vascular delivery of antioxidants. Nanomedicine 2011, 6(7):1257-1272.
2. Brenner J.S., Greineder C., Shuvaev V., Muzykantov V. Endothelial nanomedicine for the treatment of pulmonary disease. Expert Opin. Drug Deliv. 2015, 12(2):239-261.
3. Myerson J.W., Brenner J.S., Greineder C.F., Muzykantov V.R. Systems approaches to design of targeted therapeutic delivery. Wiley Interdiscip Rev Syst Biol Med May 6 2015, (Epub ahead of print).
4. Howard M., Zern B.J., Anselmo A.C., Shuvaev V.V., Mitragotri S., Muzykantov V. Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano 2014, 8(5):4100-4132.
5. Simone E., Ding B.S., Muzykantov V. Targeted delivery of therapeutics to endothelium. Cell Tissue Res. 2009, 335(1):283-300.
6. Muro S., Muzykantov V.R. Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. Curr. Pharm. Des. 2005, 11(18):2383-2401.
7. Huang R.B., Mocherla S., Heslinga M.J., Charoenphol P., Eniola-Adefeso O. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery. Mol. Membr. Biol. 2010, 27(7):312-327.
8. Corti A., Pastorino F., Curnis F., Arap W., Ponzoni M., Pasqualini R. Targeted drug delivery and penetration into solid tumors. Med. Res. Rev. 2012, 32(5):1078-1091.
9. Wickline S.A., Neubauer A.M., Winter P.M., Caruthers S.D., Lanza G.M. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. J. Magn. Reson. Imaging 2007, 25(4):667-680.
10. Noble C.O., Kirpotin D.B., Hayes M.E., Mamot C., Hong K., Park J.W., Benz C.C., Marks J.D., Drummond D.C. Development of ligand-targeted liposomes for cancer therapy. Expert Opin. Ther. Targets 2004, 8(4):335-353.
11. Xia W., Low P.S. Folate-targeted therapies for cancer. J. Med. Chem. 2010, 53(19):6811-6824.
12. Shuvaev V.V., Christofidou-Solomidou M., Scherpereel A., Simone E., Arguiri E., Tliba S., Pick J., Kennel S., Albelda S.M., Muzykantov V.R. Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium. J. Control. Release 2007, 118(2):235-244.
13. Ding B.S., Dziubla T., Shuvaev V.V., Muro S., Muzykantov V.R. Advanced drug delivery systems that target the vascular endothelium. Mol. Interv. 2006, 6(2):98-112.
14. Calderon A.J., Baig M., Pichette B., Muzykantov V., Muro S., Eckmann D.M. Effect of glycocalyx on drug delivery carriers targeted to endothelial cells. Int. J. Transp. Phenom. 2011, 12(1):63-75.
15. Shuvaev V.V., Tliba S., Pick J., Arguiri E., Christofidou-Solomidou M., Albelda S.M., Muzykantov V.R. Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates. J. Control. Release 2011, 149(3):236-241.
16. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303(5665):1818-1822.
17. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 2006, 6(9):688-701.
18. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2(12):751-760.
19. Hirsch L.R., Stafford R.J., Bankson J.A., Sershen S.R., Rivera B., Price R.E., Hazle J.D., Halas N.J., West J.L. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. 2003, 100(23):13549-13554.
20. Tasciotti E., Liu X., Bhavane R., Plant K., Leonard A.D., Price B.K., Cheng M.M., Decuzzi P., Tour J.M., Robertson F., Ferrari M. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nanotechnol. 2008, 3(3):151-157.
21. Slowing I.I., Vivero-Escoto J.L., Wu C., Lin V.S.Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60(11):1278-1288.
22. Xu Q., Hashimoto M., Dang T.T., Hoare T., Kohane D.S., Whitesides G.M., Langer R., Anderson D.G. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small 2009, 5(13):1575-1581.
23. Rolland J.P., Maynor B.W., Euliss L.E., Exner A.E., Denison G.M., DeSimone J.M. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 2005, 127(28):10096-10100.
24. Champion J.A., Katare Y.K., Mitragotri S. Particle shape: a new design parameter for micro-and nanoscale drug delivery carriers. J. Control. Release 2007, 121(1):3-9.
25. Steinmetz N.F., Shah S.N., Barclay J.E., Rallapalli G., Lomonossoff G.P., Evans D.J. Virus templated silica nanoparticles. Small 2009, 5(7):813-816.
26. Ren J., Tilley R.D. Shape controlled growth of platinum nanoparticles. Small 2007, 3(9):1508-1512.
27. Predescu S.A., Predescu D.N., Malik A.B. Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293(4):L823-L842.
28. Oh P., Borgström P., Witkiewicz H., Li Y., Borgström B.J., Chrastina A., Iwata K., Zinn K.R., Baldwin R., Testa J.E., Schnitzer J.E. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat. Biotechnol. 2007, 25(3):327-337.
29. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25(10):1165-1170.
30. Leucuta S.E. Systemic and biophase bioavailability and pharmacokinetics of nanoparticulate drug delivery systems. Curr. Drug Deliv. 2013, 10(2):208-240.
31. Fraley R., Papahadjopoulos D. Liposomes: the development of a new carrier system for introducing nucleic acid into plant and animal cells. Curr. Top. Microbiol. Immunol. 1982, 96:171-191.
32. De Jong W.H., Hagensb W.I., Krystekc P., Burgera M.C., Sipsb A.J.A.M., Geertsmad R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29(12):1912-1919.
33. Moghimi S., Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003, 42(6):463-478.
34. Owens D.E., Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006, 307(1):93-102.
35. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J. 2005, 19(3):311-330.
36. Decuzzi P., Godin B., Tanaka T., Lee S.Y., Chiappini C., Liu X., Ferrari M. Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 2010, 141(3):320-327.
37. Chen L.T. Microcirculation of the spleen: and open or closed circulation?. Science 1978, 201(4351):157-159.
38. Litzinger D.C., Buiting A.M.J., Rooijen N.V., Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta Biomembr. 1994, 1190(1):99-107.
39. Herant M., Heinrich V., Dembo M. Mechanics of neutrophil phagocytosis: experiments and quantitative models. J. Cell Sci. 2006, 119(9):1903-1913.
40. Slack J.D., Kanke M., Simmons G.H., DeLuca P.P. Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration. J. Pharm. Sci. 1981, 70(6):660-664.
41. Illum L., Davis S. The targeting of drugs parenterally by use of microspheres. PDA J. Pharm. Sci. Technol. 1982, 36(6):242-248.
42. Petros R.A., DeSimone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010, 9(8):615-627.
43. Geng Y., Dalhaimer P., Cai S., Tsal R., Tewari M., Minko T., Discher D.E. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2007, 2:249-255.
44. Liu Y., Tan J., Thomas A., Ou-Yang D., Muzykantov V.R. The shape of things to come: importance of design in nanotechnology for drug delivery. Ther. Deliv. 2012, 3(2):181-194.
45. Muro S., Garnacho C., Champion J.A., Leferovich J., Gajewski C., Schuchman E.H., Mitragotri S., Muzykantov V.R. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1 targeted carriers. Mol. Ther. 2008, 16:1450-1458.
46. Merkel T.J., Chen K., Jones S.W., Pandya A.A., Tian S., Napier M.E., Zamboni W.E., DeSimone J.M. The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. J. Control. Release 2012, 162(1):37-44.
47. Cai S., Vijayan K., Cheng D., Lima E., Discher D. Micelles of different morphologies - advantages of worm-like filomicelles of peo-pcl in paclitaxel delivery. Pharm. Res. 2007, 24:2099-2109.
48. Liu W., Zhou X., Mao Z., Yu D., Wang B., Gao C. Uptake of hydrogel particles with different stiffness and its influence on HepG2 cell functions. Soft Matter 2012, 8:9235-9245.
49. Zelikin A.N., Breheney K., Robert R., Tjipto E., Wark K. Cytotoxicity and internalization of polymer hydrogel capsules by mammalian cells. Biomacromolecules 2010, 11(8):2123-2129.
50. Mulivor A.W., Lipowsky H.H. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 2004, 286(5):H1672-H1680.
51. Mulivor A.W., Lipowsky H.H. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am. J. Physiol. Heart Circ. Physiol. 2002, 283(4):H1282-H1291.
52. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46(12 Part 1):6387-6392.
53. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999, 51(4):691-744.
54. Maeda H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J. Control. Release 2012, 164(2):138-144.
55. Mitragotri S., Lahann J. Physical approaches to biomaterial design. Nat. Mater. 2009, 8(1):15-23.
56. Chithrani B.D., Chan W.C. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7(6):1542-1550.
57. Gersh K.C., Zaitsev S., Muzykantov V., Cines D.B., Weisel J.W. The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics. J. Thromb. Haemost. 2010, 8(5):1066-1074.
58. Zaitsev S., Spitzer D., Murciano J.C., Ding B.S., Tliba S., Kowalska M.A., Bdeir K., Kuo A., Stepanova V., Atkinson J.P., Poncz M., Cines D.B., Muzykantov V.R. Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis. J. Pharmacol. Exp. Ther. 2010, 332(3):1022-1031.
59. Zaitsev S., Danielyan K., Murciano J.C., Ganguly K., Krasik T., Taylor R.P., Pincus S., Jones S., Cines D.B., Muzykantov V.R. Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood 2006, 108(6):1895-1902.
60. Korin N., Kanapathipillai M., Matthews B.D., Crescente M., Brill A., Mammoto T., Ghosh K., Jurek S., Bencherif S.A., Bhatta D., Coskun A.U., Feldman C.L., Wagner D.D., Ingber D.E. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 2012, 337:738-742.
61. Garnacho C., Albelda S.M., Muzykantov V.R., Muro S. Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes. J. Control. Release 2008, 130(3):226-233.
62. Chrastina A., Valadon P., Massey K.A., Schnitzer J.E. Lung vascular targeting using antibody to aminopeptidase P: CT-SPECT imaging, biodistribution and pharmacokinetic analysis. J. Vasc. Res. 2010, 47(6):531-543.
63. Shuvaev V.V., Ilies M.A., Simone E., Zaitsev S., Kim Y., Cai S., Mahmud A., Dziubla T., Muro S., Discher D.E., Muzykantov V.R. Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano 2011, 5:6991-6999.
64. Kolhar P., Anselmo A.C., Gupta V., Pant K., Prabhakarpandian B., Ruoslahti E., Mitragotri S. Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:10753-10758.
65. Namdee K., Thompson A.J., Golinski A., Mocherla S., Bouis D., Eniola-Adefeso O. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis. Atherosclerosis 2014, 237(1):279-286.
66. Shchepelina O., Kozlovskaya V., Kharlampieva E., Mao W., Alexeev A., Tsukruk V.V. Anisotropic micro- and nano-capsules. Macromol. Rapid Commun. 2010, 31:2041.
67. Yashchenok A., Parakhonskiy B., Donatan S., Kohler D., Skirtach A., Möhwald H. Polyelectrolyte multilayer microcapsules templated on spherical, elliptical and square calcium carbonate particles. J. Mater. Chem. B 2013, 1:1223-1228.
68. Kozlovskaya V., Wang Y., Higgins W., Chen J., Chen Y., Kharlampieva E. pH-triggered shape response of cubical ultrathin hydrogel capsules. Soft Matter 2012, 8:9828-9839.
69. Kozlovskaya V., Baggett J., Godin B., Liu X., Kharlampieva E. Hydrogen-bonded multilayers of silk fibroin: from coatings to cell-mimicking shaped microcontainers. ACS Macro Lett. 2012, 1:384-387.
70. She S., Li Q., Shan B., Tong W., Gao C. Fabrication of red-blood-cell-like polyelectrolyte microcapsules and their deformation and recovery behavior through a microcapillary. Adv. Mater. 2013, 25:5814.
71. Kozlovskaya V., Alexander J.F., Wang Y., Kuncewicz T., Liu X., Godin B., Kharlampieva E. Internalization of red blood cell-mimicking hydrogel capsules with pH-triggered shape responses. ACS Nano 2014, 8(6):5725-5737.
72. Chen J., Kozlovskaya V., Goins A., Campos-Gomez J., Saeed M., Kharlampieva E. Biocompatible shaped particles from dried multilayer polymer capsules. Biomacromolecules 2013, 14(11):3830-3841.
73. Mahaffy R.E., Shih C.K., MacKintosh F.K., Käs J. Scanning probe-based frequency-dependent microrheology of polymer gels and biological cells. Phys. Rev. Lett. 2000, 85:880-883.
74. Lam W.A., Chaudhuri O., Crow A., Webster K.D., Li T.D., Kita A., Huang J., Fletcher D.A. Mechanics and contraction dynamics of single platelets and implications for clot stiffening. Nat. Mater. 2011, 10(1):61-66.
75. Zhang H., Liu K.K. Optical tweezers for single cells. J. R. Soc. Interface 2008, 5(24):671-690.
76. Luo J., Xia G., Guo D. Mechanical properties of nanoparticles: basics and applications. J. Phys. D. Appl. Phys. 2014, 47:013001.
77. Eckmann D.M., Composto R.J., Tsourkas A., Muzykantov V.R. Nanogel carrier design for targeted drug delivery. J. Mater. Chem. B Mater. Biol. Med. 2014, 2(46):8085-8097.
78. Yuan Y.Y., Du J.Z., Song W.J., Wang F., Yang X.Z., Xiong M.H., Wang J. Biocompatible and functionalizable polyphosphate nanogel with a branched structure. J. Mater. Chem. 2012, 22:9322-9329.
79. Urakami H., Hentschel J., Seetho K., Zeng H., Chawla K., Guan Z. Surfactant-free synthesis of biodegradable, biocompatible, and stimuli-responsive cationic nanogel particles. Biomacromolecules 2013, 14(10):3682-3688.
80. Merkel T.J., Jones S.W., Herlihy K.P., Kersey F.R., Shields A.R., Napier M., Luft J.C., Wu H., Zamboni W.C., Wang A.Z., Bear J.E., DeSimone J.M. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(2):586-591.
81. Mitragotri S., Lahann J. Physical approaches to biomaterial design. Nat. Mater. 2009, 8:15-23.
82. Muzykantov V.R. Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin. Drug Deliv. 2010, 7(4):403-427.
83. Anselmo A.C., Zhang M., Kumar S., Vogus D.R., Menegatti S., Helgeson M.E., Mitragotri S. Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. ACS Nano 2015, 9(3):3169-3177.
84. Doshi N., Zahra A.S., Bhaskar S., Lahann J., Mitragotri S. Red blood cell-mimicking synthetic biomaterial particles. Proc. Natl. Acad. Sci. 2009, 106(51):21495-21499.
85. Fung Y.C. Biomechanics: Mechanical Properties of Living Tissues 1993.
86. Euliss L.E., DuPont J.A., Gratton S., DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev. 2006, 35:1095-1104.
87. Simone E.A., Dziubla T.D., Colon-Gonzalez F., Discher D.E., Muzykantov V.R. Effect of polymer amphiphilicity on loading of a therapeutic enzyme into protective filamentous and spherical polymer nanocarriers. Biomacromolecules 2007, 8(12):3914-3921.
88. Dalhaimer P., Engler A.J., Parthasarathy R., Discher D.E. Targeted worm micelles. Biomacromolecules 2004, 5(5):1714-1719.
89. Hendrickson G.R., Lyon L.A. Microgel translocation through pores under confinement. Angew. Chem. Int. Ed. 2010, 49(12):2193-2197.
90. Iyer A.S., Lyon L.A. Self-healing colloidal crystals. Angew. Chem. Int. Ed. 2009, 48(25):4562-4566.
91. Blackburn W.H., Lyon L.A. Size-controlled synthesis of monodisperse core/shell nanogels. Colloid Polym. Sci. 2007, 286(5):563-569.
92. Brown A.C., Stabenfeldt S.E., Ahn B., Hannan R.T., Dhada K.S., Herman E.S., Stefanelli V., Guzzetta N., Alexeev A., Lam W.A., Lyon L.A., Barker T.H. Ultrasoft microgels displaying emergent platelet-like behaviours. Nat. Mater. 2014, 13:1108-1114.
93. Anselmo A.C., Modery-Pawlowski C.L., Menegatti S., Kumar S., Vogus D.R., Tian L.L., Chen M., Squires T.M., Sen Gupta A., Mitragotri S. Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano 2014, 8:11243-11253.
94. Gunawan R.C., Auguste D.T. The role of antibody synergy and membrane fluidity in the vascular targeting of immunoliposomes. Biomaterials 2010, 31(5):900-907.
95. Doshi N., Orje J.N., Molins B., Smith J.W., Mitragotri S., Ruggeri Z. Platelet mimetic particles for targeting thrombi in flowing blood. Adv. Mater. 2012, 24(28):3864-3869.
96. Beningo K.A., Wang Y.l. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J. Cell Sci. 2002, 115(4):849-856.
97. Banquy X., Suarez F., Argaw A., Rabanel J.M., Grutter P., Bouchard J.F., Hildgen P., Giasson S. Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake. Soft Matter 2009, 20(5):3984-3991.
98. Rehfeldt F., Engler A.J., Eckhardt A., Ahmed F., Discher D.E. Cell responses to the mechanochemical microenvironment- implications for regenerative medicine and drug delivery. Adv. Drug Deliv. Rev. 2007, 59:1329-1339.
99. Liu J., Weller G.E.R., Zern B., Ayyaswamy P.S., Eckmann D.M., Muzykantov V.R., Radhakrishnan R. Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, atomic force microscopy experiments. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16530-16535.
100. Desjardins C., Duling B.R. Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am. J. Physiol. 1990, 258(3 Pt 2):H647-H654.
101. Charoenphol P., Huang R.B., Eniola-Adefeso O. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. Biomaterials 2010, 31:1392-1402.
102. Lee T.R., Choi M., Kopacz A.M., Yun S.Y., Liu W.K., Decuzzi P. On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better. Sci. Rep. 2013, 3:2079.
103. Samokhin G.P., Smirnov M.D., Muzykantov V.R., Domogatsky S.P., Smirnov V.N. Red blood cell targeting to collagen-coated surfaces. FEBS Lett. 1983, 154(2):257-261.
104. Samokhin G.P., Smirnov M.D., Muzykantov V.R., Domogatsky S.P., Smirnov V.N. Effect of flow rate and blood cellular elements on the efficiency of red blood cell to collagen-coated surfaces. J. Appl. Biochem. 1984, 6(1-2):70-75.
105. Namdee K., Thompson A.J., Charoenphol P., Adefeso O.E. Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels. Langmuir 2013, 29(8):2530-2535.
106. Migliorini C., Qian Y., Chen H., Brown E.B., Jain R.K., Munn L.L. Red blood cells augment leukocyte rolling in a virtual blood vessel. Biophys. J. 2002, 83(4):1834-1841.
107. Thompson A.J., Eniola-Adefeso O. Dense nanoparticles exhibit enhanced vascular wall targeting over neutrally buoyant nanoparticles in human blood flow. Acta Biomater. 2015, 21:99-108.
108. Zhang J., Johnson P.C., Popel A.S. Effects of erythrocyte deformability and aggregation on the cell free layer and apparent viscosity of microscopic blood flows. Microvasc. Res. 2009, 77(3):265-272.
109. Tan J., Thomas A., Liu Y. Influence of red blood cells on nanoparticle targeted delivery in microcirculation. Soft Matter 2011, 8(6):1934-1946.
110. Gentile F., Curcio A., Indolfi C., Ferrari M., Decuzzi P. The margination propensity of spherical particles for vascular targeting in the microcirculation. J. Nanobiotechnol. 2008, 6:9.
111. Decuzzi P., Lee S., Bhushan B., Ferrari M. A theoretical model for the margination of particles within blood vessels. Ann. Biomed. Eng. 2005, 33:179-190.
112. Thomas A., Tan J., Liu Y. Characterization of nanoparticle delivery in microcirculation using a microfluidic device. Microvasc. Res. 2014, 94:17-27.
113. Muller K., Fedosov D.A., Gompper G. Margination of micro- and nano-particles in blood flow and its effect on drug delivery. Sci. Rep. 2014, 4:4871.
114. Thompson A.J., Mastria E.M., Eniola-Adefeso O. The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow. Biomaterials 2013, 34(23):5863-5871.
115. Sevick E.M., Jain R.K. Viscous resistance to blood-flow in solid tumors - effect of hematocrit on intratumor blood viscosity. Cancer Res. 1989, 49(13):3513-3519.
116. Smirnov V.N., Domogatsky S.P., Dolgov V.V., Hvatov V.B., Klibanov A.L., Koteliansky V.E., Muzykantov V.R., Repin V.S., Samokhin G.P., Shekhonin B.V. Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc. Natl. Acad. Sci. U. S. A. 1986, 83(17):6603-6607.
117. Rossi L., Serafini S., Pierigé F., Antonelli A., Cerasi A., Fraternale A., Chiarantini L., Magnani M. Erythrocyte-based drug delivery. Expert Opin. Drug Deliv. 2005, 2(2):311-322.
118. Anselmo A.C., Mitragotri S. Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. J. Control. Release 2014, 190:531-541.
119. Batrakova E.V., Gendelman H.E., Kabanov A.V. Cell-mediated drug delivery. Expert Opin. Drug Deliv. 2011, 8(4):415-433.
120. Stephan M.T., Irvine D.J. Enhancing cell therapies from the outside in: cell surface engineering using synthetic nanomaterials. Nano Today 2011, 6(3):309-325.
121. Anselmo A.C., Gupta V., Zern B.J., Pan D., Zakrewsky M., Muzykantov V., Mitragotri S. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. ACS Nano 2013, 7(12):11129-11137.
122. Chambers E., Mitragotri S. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. J. Control. Release 2004, 100(1):111-119.
123. Imhof B.A., Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 2004, 4(6):432-444.
124. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11(11):762-774.
125. Murdoch C., Giannoudis A., Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104(8):2224-2234.
126. Dou H., Grotepas C.B., McMillan J.M., Destache C.J., Chaubal M., Werling J., Kipp J., Rabinow B., Gendelman H.E. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J. Immunol. 2009, 183(1):661-669.
127. Choi M.R., Bardhan R., Stanton-Maxey K.J., Badve S., Nakshatri H., Stantz K.M., Cao N., Halas N.J., Clare S.E. Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. Cancer Nanotechnol. 2012, 3(1-6):47-54.
128. Brynskikh A.M., Zhao Y., Mosley R.L., Li S., Boska M.D., Klyachko N.L., Kabanov A.V., Gendelman H.E., Batrakova E.V. Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine (London) 2010, 5(3):379-396.
129. Choi J., Kim H.Y., Ju E.J., Jung J., Park J., Chung H.K., Lee J.S., Lee J.S., Park H.J., Song S.Y., Jeong S.Y., Choi E.K. Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials 2012, 33(16):4195-4203.
130. Anselmo A.C., Gilbert J.B., Kumar S., Gupta V., Cohen R.E., Rubner M.F., Mitragotri S. Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. J. Control. Release 2015, 199:29-36.
131. Modery-Pawlowski C.L., Tian L.L., Pan V., McCrae K.R., Mitragotri S., Sen Gupta A. Approaches to synthetic platelet analogs. Biomaterials 2013, 34(2):526-541.
132. Coller B.S., Springer K.T., Beer J.H., Mohandas N., Scudder L.E., Norton K.J., West S.M. Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. J. Clin. Invest. 1992, 89(2):546-555.
133. Okamura Y., Fujie T., Maruyama H., Handa M., Ikeda Y., Takeoka S. Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide. Transfusion 2007, 47(7):1254-1262.
134. Bertram J.P., Williams C.A., Robinson R., Segal S.S., Flynn N.T., Lavik E.B. Intravenous hemostat: nanotechnology to halt bleeding. Sci. Transl. Med. 2009, 1(11):11-22.
135. Okamura Y., Takeoka S., Eto K., Maekawa I., Fujie T., Maruyama H., Ikeda Y., Handa M. Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute. J. Thromb. Haemost. 2009, 7(3):470-477.
136. Nishiya T., Kainoh M., Murata M., Handa M., Ikeda Y. Platelet interactions with liposomes carrying recombinant platelet membrane glycoproteins or fibrinogen: approach to platelet substitutes. Artif. Cells Blood Substit. Immobil. Biotechnol. 2001, 29(6):453-464.
137. Lashof-Sullivan M.M., Shoffstall E., Atkins K.T., Keane N., Bir C., VandeVord P., Lavik E.B. Intravenously administered nanoparticles increase survival following blast trauma. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(28):10293-10298.
138. Hu C.M.J., Fang R.H., Wang K.C., Luk B.T., Thamphiwatana S., Dehaini D., Nguyen P., Angsantikul P., Wen C.H., Kroll A.V. Nanoparticle biointerfacing by platelet membrane cloaking. Nature 2015, 526(7571):118-121.
139. Ravikumar M., Modery C.L., Wong T.L., Sen Gupta A. Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro. Biomacromolecules 2012, 13(5):1495-1502.
140. Gentile F., Chiappini C., Fine D., Bhavane R.C., Peluccio M.S., Cheng M.M., Liu X., Ferrari M., Decuzzi P. The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J. Biomech. 2008, 41:2312-2318.
141. Takeoka S., Teramura Y., Okamura Y., Tsuchida E., Handa M., Ikeda Y. Rolling properties of rGPIbalpha-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions. Biochem. Biophys. Res. Commun. 2002, 296(3):765-770.
142. Liu J., Agrawal N.J., Calderon A.J., Ayyaswamy P.S., Eckmann D.M., Radhakrishnan R. Multivalent binding of nanocarrier to endothelial cells under shear flow. Biophys. J. 2011, 101(2):319-326.
143. Ayyaswamy P.S. In fluid mechanics 2008, 765-840. Academic Press, Maryland Heights, Missouri. P.K. Kundu, I.M. Cohen (Eds.).
144. Uijttewaal W.S., Nijhof E.J., Bronkhorst P.J., Den Hartog E., Heethaar R.M. Near-wall excess of platelets induced by lateral migration of erythrocytes in flowing blood. Am. J. Physiol. Heart Circ. Physiol. 1993, 264:H1239-H1244.
145. Daum N., Tscheka C., Neumeyer A., Schneider M. Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2012, 4(1):52-65.
146. Swaminathan T.N., Mukundakrishnan K., Hu H.H. Sedimentation of an ellipsoid inside an infinitely long tube at low and intermediate Reynolds numbers. J. Fluid Mech. 2006, 551:357-385.
147. Gavze E., Shapiro M. Motion of inertial spheroidal particles in a shear flow near a solid wall with special application to aerosol transport in microgravity. J. Fluid Mech. 1998, 371:59-79.
148. Kojić M., Filipović N., Stojanović B., Kojić N. Computer Modeling in Bioengineering: Theoretical Background, Examples and Software 2008, John Wiley & Sons.
149. Cai S., Vijayan K., Cheng D., Lima E., Discher D. Micelles of different morphologies - advantages of worm-like filomicelles of peo-pcl in paclitaxel delivery. Pharm. Res. 2007, 24:2099-2109.
150. Tan J., Shah S., Thomas A., Ou-Yang H.D., Liu Y. The influence of size, shape and vessel geometry on nanoparticle distribution. Microfluid. Nanofluid. 2013, 14(1-2):77-87.
151. Shah S., Liu Y., Hu W., Gao J. Modeling particle shape-dependent dynamics in nanomedicine. J. Nanosci. Nanotechnol. 2011, 11:919-928.
152. Lee S.Y., Ferrari M., Decuzzi P. Design of bio-mimetic particles with enhanced vascular interaction. J. Biomech. 2009, 42(12):1885-1890.
153. Decuzzi P., Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 2006, 27:5307-5314.
154. Björnmalm M., Yan Y., Caruso F. Engineering and evaluating drug delivery particles in microfluidic devices. J. Control. Release 2014, 190:139-149.
155. Bhise N.S., Ribas J., Manoharan V., Zhang Y.S., Polini A., Massa S., Dokmeci M.R., Khademhosseini A. Organ-on-a-chip platforms for studying drug delivery systems. J. Control. Release 2014, 190:82-93.
156. Prabhakarpandian B., Shen M.C., Nichols J.B., Mills I.R., Sidoryk-Wegrzynowicz M., Aschner M., Pant K. SyM-BBB: a microfluidic blood brain barrier model. Lab Chip 2013, 13:1093-1101.
157. Doshi N., Prabhakarpandian B., Rea-Ramsey A., Pant K., Sundaram S., Mitragotri S. Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. J. Control. Release 2010, 146:196-200.
158. Weinbaum S., Tarbell J.M., Damiano E.R. The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 2007, 9:121-167.
159. Potter D.R., Damiano E.R. The hydrodynamically relavant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ. Res. 2008, 102:770-776.
160. Ganguly K., Murciano J.C., Westrick R., Leferovich J., Cines D.B., Muzykantov V.R. The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition. J. Pharmacol. Exp. Ther. 2007, 321(1):158-164.
161. Greineder C.F., Chacko A.M., Zaytsev S., Zern B.J., Carnemolla R., Hood E.D., Han J., Ding B.S., Esmon C.T., Muzykantov V.R. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor. PLoS One 2013, 8(11).
162. Weinbaum S., Zhang X., Han Y., Vink H., Cowin C. Mechanotransduction and flow across the endothelial glycocalyx. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7988-7995.
163. Agrawal N.J., Radhakrishnan R. The role of glycocalyx in nanocarrier-cell adhesion investigated using a thermodynamics model and monte carlo simulations. J. Phys. Chem. C 2007, 111:15848-15856.
164. Calderon A.J., Muzykantov V., Muro S., Eckmann D.M. Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. Biorheology 2009, 46:323-341.
165. Blackwell J.E., Dagia N.M., Dickerson J.B., Berg E.L., Goetz D.J. Ligand coated nanosphere adhesion to E- and P-selectin under static and flow conditions. Ann. Biomed. Eng. 2001, 29:523-533.
166. Lin A., Sabnis A., Kona S., Nattama S., Patel H., Dong J.F., Nguyen K.T. Shear-regulated uptake of nanoparticles by endothelial cells and development of endothelial-targeting nanoparticles. J. Biomed. Mater. Res. A 2010, 93A:833-842.
167. Yago T., Zarnitsyna V.I., Klopocki A.G., McEver R.P., Zhu C. Transport governs flow-enhanced cell tethering through l-selectin at threshold shear. Biophys. J. 2007, 92:330-342.
168. Marshall B.T., Long M., Piper J.W., Yago T., McEver R.P., Zhu C. Direct observation of catch bonds involving cell-adhesion molecules. Nature 2003, 423:190-193.
169. Lou J., Yago T., Klopocki A.G., Mehta P., Chen W., Zarnitsyna V.I., Bovin N.V., Zhu C., McEver R.P. Flow-enhanced adhesion regulated by a selectin interdomain hinge. J. Cell Biol. 2006, 174:1107-1117.
170. King M.R., Hammer D.A. Multiparticle adhesive dynamics: hydrodynamic recruitment of rolling leukocytes. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(26):14919-14924.
171. King M.R., Rodgers S.D., Hammer D.A. Hydrodynamic collisions suppress fluctuations in the rolling velocity of adhesive blood cells. Langmuir 2001, 17(14):4139-4143.
172. Fogelson A.L., Guy R.D. Immersed-boundary-type models of intravascular platelet aggregation. Comput. Methods Appl. Mech. Eng. 2008, 197(25-28):2087-2104.
173. Shipley R.J., Chapman S.J. Multiscale modelling of fluid and drug transport in vascular tumours. Bull. Math. Biol. 2010, 72(6):1464-1491.
174. Modok S., Scott R., Alderden R.A., Hall M.D., Mellor H.R., Bohic S., Roose T., Hambley T.W., Callaghan R. Transport kinetics of four-coordinate and six-coordinate platinum compounds in the multicell layer tumour model. Br. J. Cancer 2007, 97(2):194-200.
175. Liu Y., So R.M.C., Zhang C.H. Modeling the bifurcating flow in a human lung airway. J. Biomech. 2002, 35(4):465-473.
176. Zhang Z., Kleinstreuer C. Airflow structures and nano-particle deposition in a human upper airway model. J. Comput. Phys. 2004, 198(1):178-210.
177. Sohrabi S., Zheng J., Finol E.A., Liu Y. Numerical simulation of particle transport and deposition in the pulmonary vasculature. J. Biomech. Eng. 2014, 136(12):121010.
178. Wiewrodt R., Thomas A.P., Cipelletti L., Christofidou-Solomidou M., Weitz D.A., Feinstein S.I., Schaffer D., Albelda S.M., Koval M., Muzykantov V.R. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood 2002, 99(3):912-922.
179. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J. 2004, 377:159-169.
180. Koval M., Preiter K., Adles C., Stahl P.D., Steinberg T.H. Size of IgG-opsonized particles determines macrophage response during internalization. Exp. Cell Res. 1998, 242(1):265-273.
181. Muro S., Koval M., Muzykantov V. Endothelial endocytic pathways: gates for vascular drug delivery. Curr. Vasc. Pharmacol. 2004, 2(3):281-299.
182. Kolhar P., Mitragotri S. Polymer microparticles exhibit size and shape dependent accumulation around the nucleus after endocytosis. Adv. Funct. Mater. 2012, 22(18):3759-3764.
183. Gao H., Shi W., Freund L.B. Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(27):9469-9474.
184. Decuzzi P., Ferrari M. The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 2007, 28(18):2915-2922.
185. Decuzzi P., Ferrari M. Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 2008, 29(3):377-384.
186. Champion J.A., Mitragotri S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(13):4930-4934.
187. Decuzzi P., Ferrari M. The receptor-mediated endocytosis of nonspherical particles. Biophys. J. 2008, 94(10):3790-3797.
188. Gratton S.E.A., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., DeSimone J.M. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. 2008, 105(33):11613-11618.
189. Champion J.A., Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm. Res. 2009, 26(1):244-249.
190. Shimoni O., Yan Y., Wang Y., Caruso F. Shape-dependent cellular processing of polyelectrolyte capsules. ACS Nano 2013, 7(1):522-530.
191. Yang K., Ma Y.-Q. Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat. Nanotechnol. 2010, 5(8):579-583.
192. Pelkmans L., Helenius A. Endocytosis via caveolae. Traffic 2002, 3(5):311-320.
193. Dasgupta S., Auth T., Gompper G. Shape and orientation matter for the cellular uptake of nonspherical particles. Nano Lett. 2014, 14(2):687-693.
194. Muro S., Wiewrodt R., Thomas A., Koniaris L., Albelda S.M., Muzykantov V.R., Koval M. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J. Cell Sci. 2003, 116(8):1599-1609.
195. Xue B., Kozlovskaya V., Liu F., Chen J., Williams J.F., Campos-Gomez J., Saeed M., Kharlampieva E. Intracellular degradable hydrogel cubes and spheres for anti-cancer drug delivery. ACS Appl. Mater. Interfaces 2015, 7(24):13633-13644.
196. Bhowmick T., Berk E., Cui X., Muzykantov V.R., Muro S. Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. J. Control. Release 2012, 157(3):485-492.
197. Samuel S.P., Jain N., O'Dowd F., Paul T., Kashanin D., Gerard V.A., Gun'ko Y.K., Prina-Mello A., Volkov Y. Multifactorial determinants that govern nanoparticle uptake by human endothelial cells under flow. Int. J. Nanomedicine 2012, 7:2943-2956.
198. Terrisse A.D., Puech N., Allart S., Gourdy P., Xuereb J.M., Payrastre B., Sié P. Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J. Thromb. Haemost. 2010, 8(12):2810-2819.
199. Han J., Zern B.J., Shuvaev V.V., Davies P.F., Muro S., Muzykantov V. Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. ACS Nano 2012, 6(10):8824-8836.
200. Helmke B.P. Molecular control of cytoskeletal mechanics by hemodynamic forces. Physiology 2005, 20:43-53.
201. Cybulsky M.I., Marsden P.A. Effect of disturbed blood flow on endothelial cell gene expression: a role for changes in RNA processing. Arterioscler. Thromb. Vasc. Biol. 2014, 34(9):1806-1808.
202. Tarbell J.M. Shear stress and the endothelial transport barrier. Cardiovasc. Res. 2010, 87(2):320-330.
203. Traoré M., Sun R.J., Fawzi-Grancher S., Dumas D., Qing X., Santus R., Stoltz J.F., Muller S. Kinetics of the endocytotic pathway of low density lipoprotein (LDL) in human endothelial cells line under shear stress: an in vitro confocal microscopy study. Clin. Hemorheol. Microcirc. 2005, 33:243-251.
204. Davies P.F., Dewey C.F., Bussolari S.R., Gordon E.J., Gimbrone M.A. Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells. J. Clin. Invest. 1984, 73(4):1121-1129.
205. Muzykantov V.R., Christofidou-Solomidou M., Balyasnikova I., Harshaw D.W., Schultz L., Fisher A.B., Albelda S.M. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): A strategy for vascular immunotargeting of drugs. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2379-2384.